Published in J Virol on May 01, 2000
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J Infect Dis (2007) 3.02
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol (2004) 2.64
Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis (2009) 1.82
Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One (2009) 1.72
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc Natl Acad Sci U S A (2003) 1.37
A new insect-specific flavivirus from northern Australia suppresses replication of West Nile virus and Murray Valley encephalitis virus in co-infected mosquito cells. PLoS One (2013) 1.27
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus. Vaccine (2008) 1.10
Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol (2008) 1.01
Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol (2007) 1.01
Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J Clin Microbiol (2005) 1.01
The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulum. J Virol (2010) 0.99
Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies. Clin Vaccine Immunol (2009) 0.99
Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay. J Clin Microbiol (2004) 0.98
Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother (2013) 0.93
Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies. Clin Vaccine Immunol (2010) 0.92
Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine. J Virol (2003) 0.92
Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice. J Virol (2003) 0.90
DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. PLoS One (2011) 0.89
Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus. PLoS One (2014) 0.83
Bioinformatics in new generation flavivirus vaccines. J Biomed Biotechnol (2010) 0.81
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice. Virol J (2011) 0.81
Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector. Virology (2016) 0.80
Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route. Vaccine (2007) 0.80
Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III. PLoS Negl Trop Dis (2015) 0.78
Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine. J Virol (2014) 0.77
Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines. P R Health Sci J (2009) 0.75
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res (1984) 39.52
At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol (1987) 9.21
Phylogeny of the genus Flavivirus. J Virol (1998) 8.87
A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Int J Neural Syst (1999) 7.40
Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J Gen Virol (1978) 6.57
Eukaryotic start and stop translation sites. Nucleic Acids Res (1991) 5.57
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology (1998) 3.80
DNA-based immunization by in vivo transfection of dendritic cells. Nat Med (1996) 3.62
Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet (1996) 3.30
Segmented genome and nucleocapsid of La Crosse virus. J Virol (1976) 3.25
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J (1997) 2.96
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg (1982) 2.41
Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology (1992) 2.15
Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol (1988) 2.02
Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol (1993) 1.97
Functions of signal and signal-anchor sequences are determined by the balance between the hydrophobic segment and the N-terminal charge. Proc Natl Acad Sci U S A (1992) 1.72
The natural history of Japanese encephalitis virus. Annu Rev Microbiol (1986) 1.70
Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol (1989) 1.59
Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg (1989) 1.57
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology (1991) 1.55
A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology (1983) 1.53
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52
DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol (1998) 1.49
DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42
Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J Virol (1990) 1.42
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology (1992) 1.24
Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol (1998) 1.23
Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol (1983) 1.21
Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine (1997) 1.18
Relationships of bunyamwera group viruses by neutralization. Am J Trop Med Hyg (1979) 1.17
Transmission of immunoglobulin to foetal and neonatal mice. J Reprod Immunol (1983) 1.14
High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product. Virology (1993) 1.12
Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis (1997) 1.11
Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch Virol (1996) 1.11
Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J Med Virol (1989) 1.04
Adverse reactions to Japanese encephalitis vaccine in travellers. J Infect (1996) 1.01
Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. J Med Virol (1994) 1.00
Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis (1990) 0.97
Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine (1998) 0.96
Epitope mapping of Japanese encephalitis virus envelope protein using monoclonal antibodies against an Indian strain. J Gen Virol (1988) 0.95
Ecological studies of Japanese encephalitis virus in Hokkaido: interepidemic outbreaks of swine abortion and evidence for the virus to overwinter locally. Am J Trop Med Hyg (1988) 0.94
Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine (1997) 0.93
Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. Am J Trop Med Hyg (1990) 0.88
Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice. Vaccine (1997) 0.87
Field experiments on live attenuated Japanese encephalitis virus vaccine for swine. Biken J (1978) 0.81
The DNA sequence of human chromosome 22. Nature (1999) 30.88
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells. Nature (1984) 4.52
Outbreak of HIV infection in a Scottish prison. BMJ (1995) 3.82
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res (2001) 3.45
Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro (2014) 3.10
The influence of ethnicity and race on attitudes toward advance directives, life-prolonging treatments, and euthanasia. J Clin Ethics (1993) 2.66
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Family support and conflict: prospective relations to adolescent depression. J Abnorm Child Psychol (1997) 2.38
Gram-negative bacilli in burns. J Clin Pathol (1969) 2.35
Experimental infection of chickens as candidate sentinels for West Nile virus. Emerg Infect Dis (2001) 2.14
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci (2001) 2.13
Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation (1999) 2.09
Family processes in adolescent depression. Clin Child Fam Psychol Rev (2001) 2.07
Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus. Int J Dermatol (1993) 2.05
Suppression of leukaemia virus pathogenicity by polyoma virus enhancers. Nature (1985) 2.03
Rationale for tobacco cessation interventions for youth. Prev Med (1998) 2.01
Is diazepam an antidepressant? Br J Psychiatry (1989) 1.96
Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol (1985) 1.96
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology (1990) 1.91
Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1992) 1.80
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
Recent outcomes in the treatment of burn injury in the United States: a report from the American Burn Association Patient Registry. J Burn Care Rehabil (1995) 1.74
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) (2005) 1.72
The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J Immunol (1992) 1.71
Active transport of Na+ and Cl- across the canine tracheal epithelium in vitro. Am Rev Respir Dis (1975) 1.71
Disruption of the cytochrome c gene in xylose-utilizing yeast Pichia stipitis leads to higher ethanol production. Yeast (1999) 1.70
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg (1990) 1.66
Serological and genotypic diversity among serogroup 5- reacting environmental Legionella isolates. J Clin Microbiol (1982) 1.59
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol Appl Pharmacol (1966) 1.56
Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo. Arch Pathol Lab Med (1999) 1.53
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab (1978) 1.53
Isolation of a new flavivirus related to cell fusing agent virus (CFAV) from field-collected flood-water Aedes mosquitoes sampled from a dambo in central Kenya. Arch Virol (2003) 1.52
Perturbed pKA-values in the denatured states of proteins. J Mol Biol (1995) 1.49
The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. Am J Hypertens (1992) 1.43
Employment and salary characteristics of nurse practitioners. Nurse Pract (1989) 1.42
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
Absence of particle-induced coronary vasoconstriction during cardioplegic infusion: is it desirable to use a microfilter in the infusion line? J Thorac Cardiovasc Surg (1991) 1.39
Non-O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol (1981) 1.35
Regulation of negative affect during mother-child problem-solving interactions: adolescent depressive status and family processes. J Abnorm Child Psychol (2000) 1.33
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Compatible results obtained from biotyping and serotyping in Serratia marcescens. J Clin Microbiol (1979) 1.28
Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial. JAMA (2000) 1.28
HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol (2007) 1.27
Control of mucus secretion and ion transport in airways. Annu Rev Physiol (1979) 1.27
Prospective study of equine colic incidence and mortality. Equine Vet J (1997) 1.25
A service for the adult asthmatic. Thorax (1980) 1.24
Body composition and energy metabolism in resting and exercising muslims during Ramadan fast. J Sports Med Phys Fitness (1992) 1.23
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
Reflex tracheal gland secretion evoked by stimulation of bronchial C-fibers in dogs. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.21
The development of alcohol and other substance use: a gender study of family and peer context. J Stud Alcohol Suppl (1999) 1.20
Insulin release from mouse islets. Effect of glucose and hormones on adenylate cyclase. Biochem J (1972) 1.20
Relationships of bunyamwera group viruses by neutralization. Am J Trop Med Hyg (1979) 1.17
In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology (1988) 1.16
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Normal lumbar vertebrae: anatomic, age, and sex variance in subjects at proton MR spectroscopy--initial experience. Radiology (2000) 1.13
Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Injury (1971) 1.13
Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients. Blood (1998) 1.13
Prospective study of equine colic risk factors. Equine Vet J (1997) 1.12
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology (1985) 1.12
Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. Curr Top Microbiol Immunol (1996) 1.11
Identification of beta variant hemoglobins by DNA restriction endonuclease mapping. Hemoglobin (1984) 1.11
Atypical carcinoid of the lung. A distinct clinicopathologic entity. Chest (1988) 1.11
Evaluation of an automated deformable image matching method for quantifying lung motion in respiration-correlated CT images. Med Phys (2006) 1.10
Identification of monoclonal antibodies that recognize novel epitopes in native chondroitin/dermatan sulfate glycosaminoglycan chains: their use in mapping functionally distinct domains of human skin. J Histochem Cytochem (1990) 1.09
Hydrogen exchange in chymotrypsin inhibitor 2 probed by mutagenesis. J Mol Biol (1997) 1.07
Effectiveness of preprocedure simethicone drink in improving visibility during esophagogastroduodenoscopy: a double-blind, randomized study. J Clin Gastroenterol (1992) 1.06
The consequences of anterior femoral notching in total knee arthroplasty. A biomechanical study. J Bone Joint Surg Am (2000) 1.06
Interactional processes in families with depressed and non-depressed adolescents: reinforcement of depressive behavior. Behav Res Ther (1998) 1.06
The effects of 4-nonylphenol in rats: a multigeneration reproduction study. Toxicol Sci (1999) 1.05
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists. Br J Pharmacol (1999) 1.05
Hypothesis validity of clinical research. J Consult Clin Psychol (1990) 1.04
The structure of the transition state for the association of two fragments of the barley chymotrypsin inhibitor 2 to generate native-like protein: implications for mechanisms of protein folding. Proc Natl Acad Sci U S A (1994) 1.04
An exploratory study of environmental and medical factors potentially related to childhood cancer. Med Pediatr Oncol (1991) 1.04
The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. Blood (1995) 1.03
Effect of alpha-adrenergic stimulation on mucus secretion and on ion transport in cat trachea in vitro. Am Rev Respir Dis (1980) 1.03
Backbone dynamics of chymotrypsin inhibitor 2: effect of breaking the active site bond and its implications for the mechanism of inhibition of serine proteases. Biochemistry (1995) 1.03
Protective effect of pregnancy for development of uterine leiomyoma. Carcinogenesis (2001) 1.03
Effect of terbutaline on movement of Cl- and Na+ across the trachea of the dog in vitro. Am Rev Respir Dis (1979) 1.02
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol (1988) 1.01
An in Vitro system for studying insulin release caused by secretory granules-plasma membrane interaction: definition of the system. J Physiol (1976) 1.01
Non-invasive measurement of ventilation during exercise using a respiratory inductive plethysmograph. I. Am Rev Respir Dis (1980) 1.01
Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med (2000) 1.00
Adrenergic and cholinergic nerves mediate fluid secretion from tracheal glands of ferrets. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.00
Flavivirus DNA vaccines: current status and potential. Ann N Y Acad Sci (2001) 1.00
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest (1997) 1.00
Action of some steroids on the centtral nervous system of the mouse. II. Pharmacology. J Med Chem (1965) 0.98
The respiratory inductive plethysmograph: a new non-invasive monitor of respiration. Bull Eur Physiopathol Respir (1982) 0.98
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology (1994) 0.97
Vasoactive intestinal peptide stimulates tracheal submucosal gland secretion in ferret. Am Rev Respir Dis (1983) 0.95